Integra Lifesciences (IART)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 120,614 | 118,868 | 98,636 | 89,691 | 96,938 |
| Receivables | 118,145 | 113,538 | 114,749 | 111,944 | 114,916 |
| Inventories | 206,919 | 207,389 | 195,457 | 179,558 | 171,806 |
| Income taxes - deferred | 48,616 | 40,049 | 38,120 | 38,470 | 39,100 |
| TOTAL | $521,152 | $510,583 | $477,736 | $447,059 | $453,051 |
| Non-Current Assets | |||||
| PPE Net | 200,310 | 192,724 | 184,537 | 179,352 | 177,898 |
| Intangibles | 446,927 | 451,234 | 499,765 | 504,552 | 506,334 |
| Other Non-Current Assets | 23,750 | 29,531 | 25,463 | 25,528 | 26,316 |
| TOTAL | $670,987 | $673,489 | $709,765 | $709,432 | $710,548 |
| Total Assets | $1,192,139 | $1,184,072 | $1,187,501 | $1,156,491 | $1,163,599 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 50,752 | 54,466 | 44,767 | 43,875 | 36,742 |
| Accrued Expenses | 64,433 | 63,338 | 60,824 | 58,037 | 66,682 |
| TOTAL | $119,382 | $122,278 | $109,339 | $105,780 | $106,929 |
| Non-Current Liabilities | |||||
| Long Term Debt | 186,875 | 341,875 | 341,875 | 321,875 | 321,875 |
| Deferred Revenues | 4,197 | 4,474 | 3,748 | 3,868 | 3,505 |
| Other Non-Current Liabilities | 217,709 | 215,288 | 214,302 | 213,550 | 211,627 |
| TOTAL | $406,667 | $562,317 | $561,573 | $540,822 | $538,895 |
| Total Liabilities | $526,049 | $684,595 | $670,912 | $646,602 | $645,824 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 64,826 | 56,227 | 56,188 | 56,129 | 55,978 |
| Common Shares | 410 | 370 | 370 | 370 | 369 |
| Retained earnings | 280,956 | 272,863 | 301,413 | 297,973 | 302,023 |
| Other shareholders' equity | 806 | -834 | -9,525 | -11,402 | -4,918 |
| TOTAL | $666,090 | $499,477 | $516,589 | $509,889 | $517,775 |
| Total Liabilities And Equity | $1,192,139 | $1,184,072 | $1,187,501 | $1,156,491 | $1,163,599 |